1 Market Overview

1.1 Product Overview and Scope of Sickle Cell Anemia Therapeutics

1.2 Classification of Sickle Cell Anemia Therapeutics by Type

1.2.1 Overview: Global Sickle Cell Anemia Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type in 2021

1.2.3 Blood Transfusion

1.2.4 Pharmacotherapy

1.2.5 Bone Marrow Transplant

1.3 Global Sickle Cell Anemia Therapeutics Market by Application

1.3.1 Overview: Global Sickle Cell Anemia Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Child

1.3.3 Adult

1.4 Global Sickle Cell Anemia Therapeutics Market Size & Forecast

1.5 Global Sickle Cell Anemia Therapeutics Market Size and Forecast by Region

1.5.1 Global Sickle Cell Anemia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Sickle Cell Anemia Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Sickle Cell Anemia Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Sickle Cell Anemia Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Sickle Cell Anemia Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Sickle Cell Anemia Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Sickle Cell Anemia Therapeutics Market Drivers

1.6.2 Sickle Cell Anemia Therapeutics Market Restraints

1.6.3 Sickle Cell Anemia Therapeutics Trends Analysis

2 Company Profiles

2.1 Emmaus Medical

2.1.1 Emmaus Medical Details

2.1.2 Emmaus Medical Major Business

2.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Product and Solutions

2.1.4 Emmaus Medical Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Emmaus Medical Recent Developments and Future Plans

2.2 Addmedica

2.2.1 Addmedica Details

2.2.2 Addmedica Major Business

2.2.3 Addmedica Sickle Cell Anemia Therapeutics Product and Solutions

2.2.4 Addmedica Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Addmedica Recent Developments and Future Plans

2.3 Gamida Cell

2.3.1 Gamida Cell Details

2.3.2 Gamida Cell Major Business

2.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Product and Solutions

2.3.4 Gamida Cell Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Gamida Cell Recent Developments and Future Plans

2.4 GlycoMimetics

2.4.1 GlycoMimetics Details

2.4.2 GlycoMimetics Major Business

2.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Product and Solutions

2.4.4 GlycoMimetics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GlycoMimetics Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer Sickle Cell Anemia Therapeutics Product and Solutions

2.5.4 Pfizer Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Sickle Cell Anemia Therapeutics Product and Solutions

2.6.4 Novartis Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Novartis Recent Developments and Future Plans

2.7 Global Blood Therapeutics

2.7.1 Global Blood Therapeutics Details

2.7.2 Global Blood Therapeutics Major Business

2.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product and Solutions

2.7.4 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Global Blood Therapeutics Recent Developments and Future Plans

2.8 Micelle BioPharma

2.8.1 Micelle BioPharma Details

2.8.2 Micelle BioPharma Major Business

2.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Product and Solutions

2.8.4 Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Micelle BioPharma Recent Developments and Future Plans

2.9 Bluebird Bio

2.9.1 Bluebird Bio Details

2.9.2 Bluebird Bio Major Business

2.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Product and Solutions

2.9.4 Bluebird Bio Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Bluebird Bio Recent Developments and Future Plans

2.10 Prolong Pharmaceuticals

2.10.1 Prolong Pharmaceuticals Details

2.10.2 Prolong Pharmaceuticals Major Business

2.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product and Solutions

2.10.4 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Prolong Pharmaceuticals Recent Developments and Future Plans

2.11 Modus Therapeutics

2.11.1 Modus Therapeutics Details

2.11.2 Modus Therapeutics Major Business

2.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Product and Solutions

2.11.4 Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Modus Therapeutics Recent Developments and Future Plans

2.12 Sangamo Biosciences

2.12.1 Sangamo Biosciences Details

2.12.2 Sangamo Biosciences Major Business

2.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Product and Solutions

2.12.4 Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Sangamo Biosciences Recent Developments and Future Plans

2.13 Bioverativ

2.13.1 Bioverativ Details

2.13.2 Bioverativ Major Business

2.13.3 Bioverativ Sickle Cell Anemia Therapeutics Product and Solutions

2.13.4 Bioverativ Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Bioverativ Recent Developments and Future Plans

2.14 Imara

2.14.1 Imara Details

2.14.2 Imara Major Business

2.14.3 Imara Sickle Cell Anemia Therapeutics Product and Solutions

2.14.4 Imara Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Imara Recent Developments and Future Plans

2.15 Ironwood Pharmaceuticals

2.15.1 Ironwood Pharmaceuticals Details

2.15.2 Ironwood Pharmaceuticals Major Business

2.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product and Solutions

2.15.4 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Ironwood Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Sickle Cell Anemia Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Sickle Cell Anemia Therapeutics Players Market Share in 2021

3.2.2 Top 10 Sickle Cell Anemia Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Sickle Cell Anemia Therapeutics Players Head Office, Products and Services Provided

3.4 Sickle Cell Anemia Therapeutics Mergers & Acquisitions

3.5 Sickle Cell Anemia Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Sickle Cell Anemia Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Sickle Cell Anemia Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Sickle Cell Anemia Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Sickle Cell Anemia Therapeutics Revenue by Type (2017-2028)

6.2 North America Sickle Cell Anemia Therapeutics Revenue by Application (2017-2028)

6.3 North America Sickle Cell Anemia Therapeutics Market Size by Country

6.3.1 North America Sickle Cell Anemia Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Sickle Cell Anemia Therapeutics Revenue by Type (2017-2028)

7.2 Europe Sickle Cell Anemia Therapeutics Revenue by Application (2017-2028)

7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Country

7.3.1 Europe Sickle Cell Anemia Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region

8.3.1 Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Region (2017-2028)

8.3.2 China Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Sickle Cell Anemia Therapeutics Revenue by Type (2017-2028)

9.2 South America Sickle Cell Anemia Therapeutics Revenue by Application (2017-2028)

9.3 South America Sickle Cell Anemia Therapeutics Market Size by Country

9.3.1 South America Sickle Cell Anemia Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country

10.3.1 Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Sickle Cell Anemia Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Sickle Cell Anemia Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Sickle Cell Anemia Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Sickle Cell Anemia Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Sickle Cell Anemia Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. Emmaus Medical Corporate Information, Head Office, and Major Competitors

Table 7. Emmaus Medical Major Business

Table 8. Emmaus Medical Sickle Cell Anemia Therapeutics Product and Solutions

Table 9. Emmaus Medical Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Addmedica Corporate Information, Head Office, and Major Competitors

Table 11. Addmedica Major Business

Table 12. Addmedica Sickle Cell Anemia Therapeutics Product and Solutions

Table 13. Addmedica Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Gamida Cell Corporate Information, Head Office, and Major Competitors

Table 15. Gamida Cell Major Business

Table 16. Gamida Cell Sickle Cell Anemia Therapeutics Product and Solutions

Table 17. Gamida Cell Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GlycoMimetics Corporate Information, Head Office, and Major Competitors

Table 19. GlycoMimetics Major Business

Table 20. GlycoMimetics Sickle Cell Anemia Therapeutics Product and Solutions

Table 21. GlycoMimetics Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Pfizer Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer Major Business

Table 24. Pfizer Sickle Cell Anemia Therapeutics Product and Solutions

Table 25. Pfizer Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Novartis Corporate Information, Head Office, and Major Competitors

Table 27. Novartis Major Business

Table 28. Novartis Sickle Cell Anemia Therapeutics Product and Solutions

Table 29. Novartis Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Global Blood Therapeutics Corporate Information, Head Office, and Major Competitors

Table 31. Global Blood Therapeutics Major Business

Table 32. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product and Solutions

Table 33. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Micelle BioPharma Corporate Information, Head Office, and Major Competitors

Table 35. Micelle BioPharma Major Business

Table 36. Micelle BioPharma Sickle Cell Anemia Therapeutics Product and Solutions

Table 37. Micelle BioPharma Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Bluebird Bio Corporate Information, Head Office, and Major Competitors

Table 39. Bluebird Bio Major Business

Table 40. Bluebird Bio Sickle Cell Anemia Therapeutics Product and Solutions

Table 41. Bluebird Bio Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Prolong Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 43. Prolong Pharmaceuticals Major Business

Table 44. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product and Solutions

Table 45. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Modus Therapeutics Corporate Information, Head Office, and Major Competitors

Table 47. Modus Therapeutics Major Business

Table 48. Modus Therapeutics Sickle Cell Anemia Therapeutics Product and Solutions

Table 49. Modus Therapeutics Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Sangamo Biosciences Corporate Information, Head Office, and Major Competitors

Table 51. Sangamo Biosciences Major Business

Table 52. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product and Solutions

Table 53. Sangamo Biosciences Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Bioverativ Corporate Information, Head Office, and Major Competitors

Table 55. Bioverativ Major Business

Table 56. Bioverativ Sickle Cell Anemia Therapeutics Product and Solutions

Table 57. Bioverativ Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Imara Corporate Information, Head Office, and Major Competitors

Table 59. Imara Major Business

Table 60. Imara Sickle Cell Anemia Therapeutics Product and Solutions

Table 61. Imara Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Ironwood Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 63. Ironwood Pharmaceuticals Major Business

Table 64. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product and Solutions

Table 65. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Sickle Cell Anemia Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Sickle Cell Anemia Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Sickle Cell Anemia Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Sickle Cell Anemia Therapeutics Players Head Office, Products and Services Provided

Table 70. Sickle Cell Anemia Therapeutics Mergers & Acquisitions in the Past Five Years

Table 71. Sickle Cell Anemia Therapeutics New Entrants and Expansion Plans

Table 72. Global Sickle Cell Anemia Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 73. Global Sickle Cell Anemia Therapeutics Revenue Share by Type (2017-2022)

Table 74. Global Sickle Cell Anemia Therapeutics Revenue Forecast by Type (2023-2028)

Table 75. Global Sickle Cell Anemia Therapeutics Revenue by Application (2017-2022)

Table 76. Global Sickle Cell Anemia Therapeutics Revenue Forecast by Application (2023-2028)

Table 77. North America Sickle Cell Anemia Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Sickle Cell Anemia Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Sickle Cell Anemia Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Sickle Cell Anemia Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Sickle Cell Anemia Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Sickle Cell Anemia Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Sickle Cell Anemia Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Sickle Cell Anemia Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Sickle Cell Anemia Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Sickle Cell Anemia Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Sickle Cell Anemia Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Sickle Cell Anemia Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Sickle Cell Anemia Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Sickle Cell Anemia Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Sickle Cell Anemia Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Sickle Cell Anemia Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Sickle Cell Anemia Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Sickle Cell Anemia Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Sickle Cell Anemia Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Sickle Cell Anemia Therapeutics Picture

Figure 2. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type in 2021

Figure 3. Blood Transfusion

Figure 4. Pharmacotherapy

Figure 5. Bone Marrow Transplant

Figure 6. Sickle Cell Anemia Therapeutics Revenue Market Share by Application in 2021

Figure 7. Child Picture

Figure 8. Adult Picture

Figure 9. Global Sickle Cell Anemia Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 10. Global Sickle Cell Anemia Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Region (2017-2028)

Figure 12. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Region in 2021

Figure 13. North America Sickle Cell Anemia Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Europe Sickle Cell Anemia Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. South America Sickle Cell Anemia Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Sickle Cell Anemia Therapeutics Market Drivers

Figure 19. Sickle Cell Anemia Therapeutics Market Restraints

Figure 20. Sickle Cell Anemia Therapeutics Market Trends

Figure 21. Emmaus Medical Recent Developments and Future Plans

Figure 22. Addmedica Recent Developments and Future Plans

Figure 23. Gamida Cell Recent Developments and Future Plans

Figure 24. GlycoMimetics Recent Developments and Future Plans

Figure 25. Pfizer Recent Developments and Future Plans

Figure 26. Novartis Recent Developments and Future Plans

Figure 27. Global Blood Therapeutics Recent Developments and Future Plans

Figure 28. Micelle BioPharma Recent Developments and Future Plans

Figure 29. Bluebird Bio Recent Developments and Future Plans

Figure 30. Prolong Pharmaceuticals Recent Developments and Future Plans

Figure 31. Modus Therapeutics Recent Developments and Future Plans

Figure 32. Sangamo Biosciences Recent Developments and Future Plans

Figure 33. Bioverativ Recent Developments and Future Plans

Figure 34. Imara Recent Developments and Future Plans

Figure 35. Ironwood Pharmaceuticals Recent Developments and Future Plans

Figure 36. Global Sickle Cell Anemia Therapeutics Revenue Share by Players in 2021

Figure 37. Sickle Cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Sickle Cell Anemia Therapeutics Revenue Market Share in 2021

Figure 39. Global Top 10 Players Sickle Cell Anemia Therapeutics Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Sickle Cell Anemia Therapeutics Revenue Share by Type in 2021

Figure 42. Global Sickle Cell Anemia Therapeutics Market Share Forecast by Type (2023-2028)

Figure 43. Global Sickle Cell Anemia Therapeutics Revenue Share by Application in 2021

Figure 44. Global Sickle Cell Anemia Therapeutics Market Share Forecast by Application (2023-2028)

Figure 45. North America Sickle Cell Anemia Therapeutics Sales Market Share by Type (2017-2028)

Figure 46. North America Sickle Cell Anemia Therapeutics Sales Market Share by Application (2017-2028)

Figure 47. North America Sickle Cell Anemia Therapeutics Revenue Market Share by Country (2017-2028)

Figure 48. United States Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Sickle Cell Anemia Therapeutics Sales Market Share by Type (2017-2028)

Figure 52. Europe Sickle Cell Anemia Therapeutics Sales Market Share by Application (2017-2028)

Figure 53. Europe Sickle Cell Anemia Therapeutics Revenue Market Share by Country (2017-2028)

Figure 54. Germany Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Sickle Cell Anemia Therapeutics Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Sickle Cell Anemia Therapeutics Revenue Market Share by Region (2017-2028)

Figure 62. China Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Sickle Cell Anemia Therapeutics Sales Market Share by Type (2017-2028)

Figure 69. South America Sickle Cell Anemia Therapeutics Sales Market Share by Application (2017-2028)

Figure 70. South America Sickle Cell Anemia Therapeutics Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Sickle Cell Anemia Therapeutics Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Sickle Cell Anemia Therapeutics Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Sickle Cell Anemia Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source